JAGX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Jaguar Health Inc (JAGX) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock lacks positive momentum, has weak financial performance, and no significant catalysts or trading signals to support a buy decision at this time.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 43.092, showing no clear overbought or oversold conditions. Moving averages are converging, which suggests a lack of a strong trend. The stock is trading below the pivot level of 0.396, with key support at 0.356 and resistance at 0.436.
NULL identified. No recent news or significant insider/hedge fund activity.
Pre-market price is down -4.84%. Financial performance is weak with declining revenue, negative EPS growth, and a significant drop in gross margin. The stock has a 60% chance of dropping -5.9% in the next day.
In Q4 2025, revenue dropped by -7.81% YoY to $3,235,000. Net income improved but remains negative at -$23,202,000, up 133.89% YoY. EPS dropped significantly by -78.97% YoY to -4.38. Gross margin fell by -61.98% YoY to 31.99%. Overall, the financials indicate poor growth trends.
No analyst ratings or price target changes available.
